News - Appointments

Jonathan Montagu joins board of OMass Therapeutics

Read more

John Haurum joins board of Storm Therapeutics

Read more

Adrian Rawcliffe to become CEO at Adaptimmune

Read more

Thomas Kleen becomes CSO at Immodulon Therapeutics

Read more

Thomas Schinecker to head Roche Diagnostics

Read more

Bartu Ahiska to lead commercialisation at Oxford BioDynamics

Read more

Edwina Baskin-Bey becomes CMO at Nanobiotix

Read more

Seamus O’Neill named chief executive of UK health alliance

Read more

Iain McGill becomes CEO of Quell Therapeutics

Read more

Sylvie Ryckebusch joins board of Domain Therapeutics

Read more